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Introduction. Sacropexy is a generally applied treatment of prolapse, yet there are known possible complications of it. An essential
need exists for better alloplastic materials. Methods. Between April 2013 and June 2014, we performed a modified laparoscopic
bilateral sacropexy (MLBS) in 10 patients using a MRI-visible PVDF mesh implant. Selected patients had prolapse POP-Q stages
II-III and concomitant OAB. We studied surgery-related morbidity, anatomical and functional outcome, and mesh-visibility in
MRI. Mean follow-up was 7.4 months. Results. Concomitant colporrhaphy was conducted in 1/10 patients. Anatomical success was
defined as POP-Q stage 0-I. Apical success rate was 100% and remained stable. A recurrent cystocele was seen in 1/10 patients
during follow-up without need for intervention. Out of 6 (6/10) patients with preoperative SUI, 5/6 were healed and 1/6 persisted.
De-novo SUI was seen in 1/10 patients. Complications requiring a relaparoscopy were seen in 2/10 patients. 8/10 patients with OAB
were relieved postoperatively. The first in-human magnetic resonance visualization of a prolapse mesh implant was performed and
showed good quality of visualization. Conclusion. MLBS is a feasible and safe procedure with favorable anatomical and functional
outcome and good concomitant healing rates of SUI and OAB. Prospective data and larger samples are required.
1. Introduction
Surgical treatment of pelvic organ prolapse (POP) underwent
a remarkable transformation over the last decade. Starting
with facilitated use of vaginal meshes through simplified
mesh kits and followed by Food and Drug Administration
(FDA) warnings about their safety there has been a change
in practice patterns among urogynecologists. One of the
observed trends seems to be a decrease of vaginal mesh use
and an increase in sacropexy [1–3].
Abdominal sacropexy which represents the “gold stan-
dard” in POP surgery is associated with apical success rates of
93–99% alongwith low recurrence rates [4].The laparoscopic
sacropexy seems to achieve similar success rates in addition
to having advantages of less blood loss, reduced morbidity,
and shorter hospital stay [5].
Nevertheless it seems that postoperative dysfunctionmay
have a negative effect upon patient’s satisfaction. New onset
bowel (10–50%), voiding (18%), and sexual (8%) dysfunction
after sacropexy have been described [6–8]. In current litera-
ture reports on de-novo stress incontinence after sacropexy,
as well as on the obstructed defecation syndrome, are to be
found [9, 10]. A further possible complication after sacropexy
ismesh erosion. In some recent publications the rates ofmesh
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Thus there is a challenge to optimize this procedure by site
specific defect repair to obtain a better anatomic reconstruc-
tion.
Furthermore, the chosen alloplasticmaterial according to
its biomechanical characteristics may play a role in minimiz-
ing mesh-related complications. There are some data availa-
ble about nonpolypropylene meshes [12, 13]. In an effort to
increase patient’s safety some of thesemeshes have been deve-
loped to be MRI-visible [14].
The objective of this study was, therefore, to investigate
the safety and outcome of a modification of laparoscopic sac-
ropexy in an effort to abate postoperative complications and
dysfunction. In this procedurewe utilized aMRI-visiblemesh
implant with good biomechanical characteristics.
2. Material and Methods
We report on patients who underwent modified laparoscopic
bilateral sacropexy (MLBS) betweenApril 2013 and June 2014.
The selected patients consisted of women with symp-
tomatic uterine or vault prolapse ICS POP-Q stages II or III
along with overactive bladder OAB symptoms.The OAB was
diagnosed either by urodynamic, micturition diary, or both.
Patients with previous vault prolapse surgery of any kind and
those with contraindications for sacropexy were excluded.
In patients with previous hysterectomy we performed a
sacrocolpopexy and in those without previous hysterectomy
we performed a laparoscopic supracervical hysterectomy
along with a sacrocervicopexy. In the latter a negative pap-
smear no older than 6 months was required preoperatively.
Out of 32 patients that fulfilled thementioned criteria and
who were eligible for sacropexy in terms of adherence to the
guidelines only 10 patients decided to undergo MLBS after
obtaining informed consent.
To ensure patients’ safety we conducted a very strict and
frequent follow-up program. Patients were invited to the fol-
low-up at 1, 3, 6, and 12 months. The follow-up took place at
the urogynecology department and included a gynecologic
examination, a POP-Q determination, and evaluation ofmic-
turition diaries.
All patients signed up an informed consent giving per-
mission to use their medical data.
2.1. Surgical Procedure
2.1.1. Intra-Operative Setting. The procedure is performed
under general anesthesia in the dorsal lithotomy position.
A 14-F catheter is inserted into the bladder and a uterus or
vaginal manipulator is placed transvaginally.
After establishing a CO
2
-pneumoperitoneum a 10mm
transumbilical trocar is used for the laparoscopy. Two addi-
tional 5mm access ports are placed medial to and 3 cm
superior to the anterior superior iliac spine laterally to the
epigastric vessels on each side. One 12mmaccess port (12mm
Versaport) is placed 3 cm superior to the symphysis pubis.
2.1.2. Dissection of the Lower Point of Mesh Attachment. In
patients with previous hysterectomy we performed a dis-
section of the vaginal stump and in those without previous
hysterectomyweperformed a laparoscopic supracervical hys-
terectomy.
2.1.3. Dissection of a Tunnel for Mesh Placement along the Lat-
eral Pelvic Wall at Each Side. In order to perform a site spe-
cific repair of the impaired uterine suspension dissection
of a peritoneal tunnel for later mesh placement through
the superficial portion of the uterosacral ligament (USLs) is
undertaken.
Identifying the USL is facilitated by ventral traction at
the cervical stump or the vault via vaginal manipulator and
simultaneous lifting of the rectum cranially and to the con-
tralateral side. After the peritoneal fold overlying the USLs
is depicted blunt dissection of a subperitoneal tunnel is
performed using a 5mm overholt-clamp utilized through the
contralateral lower access port.
The preparation is started on the right side and is per-
formed strictly subperitoneally to avoid injury to nearby
ureter or parts of the inferior hypogastric plexus (IHP).
The sacral end of the created tunnel corresponds to the
upper insertion point of the uterosacral ligaments (USL).This
point lays on the anterior surface of the sacrum 3 cm caudal
to the promontory and 1.5 cm lateral to the midline. Having
identified this point of insertion, the overlying peritoneum
is incised and the underlying tissue is bluntly dissected: iliac
vessels are bluntly pushed laterally and tissue containing parts
of the IHP is pushed medially, thus revealing the periosteum
of the anterior surface of S2.
On the left side the procedure is performed identically. It
is important to mention that the preparation at the left side
is far more difficult due to the anatomical lay of the rectosig-
moid junction that must be sufficiently mobilized (Figure 1).
2.1.4. Lower Mesh Fixation/Fixation on the Descent Part. The
mesh is inserted via the 12mmport.The utilizedmesh is knit-
ted from nonabsorbable, biostable polyvinylidene fluoride
(PVDF) monofilament. We used one of two meshes (Dyna-
Mesh-CESA for sacrocervicopexy and DynaMesh-VASA for
sacrocolpopexy). Each consists of two thin mesh arms to be
placed alongside the lateral pelvic wall with broad ends to be
used for sacral fixation and a central part to be attached to the
cervical stump or vaginal vault.
A nonabsorbable suture (2.0 Ethibond) is used to fix the
central part of the mesh by four simple interrupted sutures.
In case of sewing the mesh to the vaginal vault the same
suture can be used but attention should be paid to prevent
penetrating the full thickness of the vaginal wall (Figure 2).
2.1.5. Bilateral Mesh Placement through the Created Tunnels.
Now the tip of the thin right mesh arm is pulled through the
formerly created tunnel. The same is done on the left side,
thus achieving a reinforcement of the USLs (Figure 3).
2.1.6. Sacral Fixation at the Level of the Upper Boarder of S2.
Two interrupted nonabsorbable sutures (2.0 Ethibond) are
used for the fixation of the broad end of the lateral mesh arm
to the periosteum of the anterior surface of S2 at each side
(Figure 4).





2.1.7. Peritoneal Closure. Closure of the peritoneum is achiev-
ed via a continuous suture with an absorbable suture (3.0
Vicryl).
2.2. Visualizing the Mesh in Magnetic Resonance Imaging
(MRI). Imaging was performed on a 1.5 Tesla Magnet (Mag-
netom-Aera Siemens, Erlangen, Germany) using a body-
array surface coil, placed over the pelvis.
Table 1: Pre-operative/baseline characteristics.
Age (yrs., mean) 62





Mode of delivery (𝑛)
Spontaneous 10/10
C. section/Forceps 0/10
Other obstetric risk factors (𝑛)
Birth weight > 4,000 gr. 0/10
Birth weight > 4,500 gr. 2/10




Hormone replacement therapy (𝑛) 3/8








∗One of these three patients has had an anterior colporrhaphy twice in her
past medical history.
∗∗This patient has had a posterior colporrhaphy twice in her past medical
history.
Imaging protocol included both 3D and 2D T1-weighted
and T2-weighted sequences. For optimal depiction of the
implants, coronal minimum-intensity projections of the 3D
datasets were performed.
3. Results
We had performed the MLBS on 10 patients between April
2013 and June 2014. All the operations were performed by the
same surgeon at an academic university hospital in Germany.
Preoperative risk factors and morbidity data were ana-
lyzed. Table 1 shows the baseline characteristics. We noticed
that all patients had given birth via spontaneous vaginal deliv-
ery and that 6 (6/10) of them have had 3 or more deliveries.
Furthermore, 2 (2/10) of the patients have had a macrosomic
baby weighing ≥ 4,500 grams.
In terms of previous prolapse surgery, 2 (2/10) patients
have had previous anterior colporrhaphy and 1 (1/10) patient
has had concomitant anterior and posterior colporrhaphy for
two times in her past medical history.
Regarding the prolapse, 4 (4/10) patients were POP-
Q stages II and 6 (6/10) POP-Q stage III preoperatively
(Table 2). We took the mean of each POP-Q measurement in
all patients to estimate the POP-Q stage resulting from the
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Table 2: Pre- and postoperative quantification of the prolapse.
POP-Q measurements (cm)
Aa Ba C D Ap Bp
Preoperative
Mean 1.2 2.1 −0.2 −1.5 −2.1 −2.1
Median 1.0 1.5 −0.5 −2.0 −2.5 −2.5
Range 0 to +3 0 to +5 −4 to +3 −4 to +1 −3 to +1 −3 to +1
𝑛 10 10 10 7∗ 10 10
Postoperative
Mean −1.5 −1.1 −6.3 −8.0 −2.7 −2.7
Median −1.0 −1.0 −6.0 −8.0 −3.0 −3.0
Range −3 to 0 −3 to 0 −7 to −5 −7 to −9 −3 to −1 −3 to −1
𝑛 10 10 10 7∗ 10 10
Diff. postoperative to preoperative
Mean 2.7 3.2 6.1 6.5 0.6 0.6
Median 2 2.5 5.5 6 0.5 0.5
Range 1 to 4 1 to 6 3 to 10 4 to 10 0 to 3 0–3
𝑛 10 10 10 7∗ 10 10
∗3 patients had a hysterectomy in their past medical history, so that measurement D is not applicable.
Table 3: Pre- and postoperative quantification of the prolapse in respect of each compartment.
POP-Q measurement (cm) and POP-Q stage according
to each compartment Ant. compartment Mid. compartment Post. compartment
Preoperative
Mean Aa: +1.2/Ba: +2.1 C: −0.2/D: −1.5 Ap: −2.1/Bp: −2.1
Mean Stage III Stage II Stage I
Median Stage III Stage II Stage I
𝑛 10 10 10
Postoperative
Mean Aa: −1.5/Ba: −1.1 C: −6.3/D: −8.0 Ap: −2.7/Bp: −2.7
Mean Stage I Stage 0 Stage 0
Median Stage I Stage 0 Stage 0
𝑛 10 10 10
descent of each compartment by its own (Table 3) to facilitate
later comparison with the postoperative results.
All selected patients were suffering from urgency and
frequency, of whom 9 (9/10) suffered from OAB-dry and 1
(1/10) fromOAB-wet. Further 6 (6/10) patients were suffering
from stress urinary incontinence (SUI). The mean frequency
of micturition was 13.3mic./d. and the mean nocturia was 2.3
micturitions/night (Table 4).
Table 5 shows the perioperative data. Low blood loss is
reflected by rather small change in hemoglobin levels post-
operatively. Regarding concomitant operations, only 1 (1/10)
patient required an anterior and posterior colporrhaphy. In
the other 9 (9/10) patients the anterior andposterior compart-
ments were sufficiently corrected after performing theMLBS.
Anatomical success was defined as POP-Q stage 0 or I.
Postoperative results show that 2 (2/10) patients were POP-Q
stage 0 and 8 (8/10) were POP-Q stage I.
Using the mean of each POP-Q measurement in all
patients to estimate the POP-Q stage of each compartment by
its own shows a mean postoperative POP-Q stage 0 for the
middle and posterior compartments and a POP-Q stage I for
the anterior compartment (Table 3).
The difference between the pre- and postoperative status
is lined out in Figure 5.
Postoperative evaluation of urinary incontinence showed
that 8 (8/10) patients did not suffer from OAB anymore,
whereas 1 (1/10) patient had persistent OAB-dry. One other
patient (1/10) had a reduction of her urgency and frequency
that was reduced postoperatively from 11 to 7-8mic./d. Yet she
reported bothersome mild urgency despite absent proof of
OAB. We regarded that as persistent OAB (Table 4).
Out of 6 (6/10) patients with preoperative SUI only 1
(1/6) patient had persistent SUI postoperatively. Additionally
1 (1/10) patient was diagnosed with de-novo SUI. The mean
frequency of micturition was reduced to 8mic./d. and the
mean nocturia to 1.2 micturitions/night (Table 4).
Table 6 shows patients’ adherence to the follow-up exam-
inations conducted in our department of urogynecology. At
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Table 4: Pre- and postoperative quantification of the urinary incontinence.






Preoperative 9/10 (90%) 1/10 (10%) 6/10 (60%) 3/10 (30%) 3/10 (30%) 13.3 2.3 2
𝑛: 10 10 10 10 10 10 8
Postoperative 2/10∗∗ (10%) 0/10 (0%) 2/10 (20%) 0/10 (0%) 2/10 (20%) 8.6 1.2 0.4
𝑛: 10 10 10 10 8 8 7
∗
𝑛./d.: number per day.
∗∗One other patient had no evidence of OAB in the urodynamic or micturition diary and still reported urgency.
Table 5: Intra- and perioperative data.
Concomitant surgery (𝑛)










Postoperative before discharge 12.4
Need for analgesics postoperatively (𝑛, %)
Piritramid 0–6 h. 9/10
Piritramid or other short acting opioids 6–48 h.∗ 1/10
NSAID in medium dose 6–48 h. 7/10
NSAID in low dose 6–48 h. 3/10
NSAID regularly in a low dose 3–5 d. 2/10
NSAID on demand in a low dose 3–5 d. 6/10
NSAID on demand in a low dose beyond 6 d.∗∗ 1/10
Hospital stay (days)
Mean 5.9
Range 3 to 11
∗Given in the intermediate care unit (ICU).
∗∗This patient was discharged and took NSAID on demand at home.
times 4 (4/10) patients had completed the one-year follow-up,
whereas the average follow-up for all patients was 7.4months.
3.1. Complications. Postoperative complications were care-
fully analyzed and are listed in Table 7. We classified these
complications by using theClavien-Dindo grading of surgical
complications [15, 16].
Furthermore, we divided the complications into early,
midterm, and late complication according to the time of their
occurrence.
Regarding early complications, one (1/10) patient suffered
from paresthesia of the right thigh.We performed aMRI that
revealed the implanted mesh in the desired lay and ruled out
any neural compression or hematoma (Figures 6 and 7).















−2 −4 −6 −8 −10
Figure 5: Correction of prolapse in each compartment. The dots
correlate to themeanmeasurements of Aa, Ba, C, D, Ap, and Bp. Red
line: lines out the preoperative status (POP-Qmeasurements). Green
line: lines out the postoperative status (POP-Q measurements)
before discharge.
The symptoms declined after reassurance and use of
NSAID for a few days and had completely resolved 1 month
postoperatively.The same patient suffered from de-novo SUI,
which required a placement of a TVT. Since the procedure
was performed under regional anesthesia the patient was
classified as suffering a complication grade IIIa.
Furthermore, 1 (1/10) patient suffered frompersisting SUI,
which required a placement of a TVT and 2 (2/10) patients
reported mild pain in the sacral region, which was treated by
NSAID in a low dose on demand for 2-3 weeks.There was no
need for further intervention as the pain resolved in less than
3 weeks.
One (1/10) patient required a relaparoscopy on the second
day postoperatively due to a hematoma of the right pelvic
wall. The bleeding showed to be from the right ovarian vein
and management required a laparoscopic salpingooophorec-
tomy. This patient additionally had a recurrent UTI that
was treated with an antibiotic. Since management of this
patient required general anesthesia the patient was classified
as suffering a complication grade IIIb.
There were nomidterm complications whereas follow-up
revealed one late complication comprising lower abdominal
pain. Diagnostic laparoscopy revealed a 1.5 cm long opening
in the peritoneum overlying the right lateral mesh arm app-
roximately 2 cm from the cervical attachment point. Laparo-
scopic mobilizing of the peritoneum and closure above the
underlying portion of the mesh were performed.
During the whole follow-up no vaginal mesh erosion, no
chronic pelvic pain and no dyspareunia were seen. Apical
success was observed in all the 10 (100%) patients and
persisted throughout follow-up.
No recurrent prolapse surgery had to be performed. Only
1 (1/10) patient had a recurrence in the anterior compartment
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Table 6: Follow-up examinations.
Follow-up 1 Follow-up 2 Follow-up 3 Follow-up 4 Follow-up
3–6 weeks 2–4 months 6-7 months 11–14 months (mean/range)
Follow-up completed (𝑛) 1/10 9/10 6/10 4/10 7.4 months/1 to 14 months
Table 7: Description and classification of postoperative complications according to the Clavien-Dindo grading system.
Post-operative




days 01 to 30
Intraperitoneal hematoma∗ Relaparoscopy day 2 Grade IIIb
1/10 1/10
Recurrent UTI∗ Antibiotics Grade I
1/10 1/10
Paraesthesia in right thigh∗∗ MRI/spontaneous resolving Grade I
1/10 1/10
De-novo SUI∗∗ Urodynamics/TVT Grade IIIa
1/10 1/10
Persistent SUI Urodynamics/TVT Grade IIIa
1/10 1/10
Mild sacral pain Reassurance/NSAID Grade I
2/10 2/10
Midterm complications
days 31 to 90 None
Late complications
>90 days
Lower abdominal pain (erosion of
the peritoneum) Relaparoscopy day 119 Grade IIIb
1/10 1/10
Recurrence of a mild cystocele Not bothersome, no treatment. Grade I
1/10
Intraperitoneal Hematoma∗ and
adhesions. Relaparoscopy Grade IIIb
1/10 1/10
∗The same patient in 3 occasions: 2 early and 1 late complications.
∗∗The same patient in 2 occasions: 2 early complications.
at 13 months follow-up showing a mild cystocele without any
discomfort. Since the patient had normal bladder function
and no relevant residual volume, no correctionwas indicated.
Thus to summarize the early complications we say that
one patient had a complication classified as Clavien-Dindo
grade I (UTI) and another one classified as Clavien-Dindo
grade IIIb (hematoma).
Another patient had one complication classified as Cla-
vien-Dindo grade I (spontaneous resolving paresthesia of the
thigh) and another one classified as Clavien-Dindo grade IIIa
(de-novo SUI). A third patient had a complication classified
as Clavien-Dindo grade IIIa (persistent SUI).
That means that we had early complications requiring
a higher pharmacologic, surgical, or radiologic intervention
(Clavien-Dindo grades higher than grade I) in 3 (3/10)
patients, representing the relevant early complication rate.
4. Discussion
The uterosacral and cardinal ligaments (CL) are regarded
the main anatomical support of the uterus and vault [17]. In
a MRI-based study DeLancey estimated the lines of action
and the tension load of both USL and CL showing that
thetension on these ligaments is affected by their orientations
[18].
As for the anatomical lay and histologic composition the
USL can be divided into a superficial (USLs) and deep (USLd)
part. The superficial part mainly comprises smooth muscle
and connective tissue, whereas the deep part is of a neurovas-
cular composition, as is the CL.
Taking this in regard, the USLs seem to be the best
accessible and anatomically safest part of both ligaments to
operate on.Thusmaking it the most suitable to perform a site
specific prolapse repair upon.
Regarding the operative technique, the critical steps are
the dissection of a tunnel along the USLs and the dissection
at the sacrum at the level of S2.
The dissection of the tunnel has to be strictly subperito-
neally. In themiddle part of the uterosacral ligament (and the
dissected canal) the distance to the ureter is 1–1.5 cm [19, 20].
Furthermore attention is paid to perform strict superficial
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Figure 6: Coronal subvolume minimum intensity projection of a
T2-weighted dataset, displaying the implant with a low signal inten-
sity (arrows), comparable to the signal of muscle tissue.
preparation in order to keep a safe distance to theUSLd which
is the neurovascular part.
Due to limited access when using a rigid laparoscopic
instrument to create a curved tunnel of 5-6 cm of length,
overdue tension at the peritoneum during dissection may
accidently be applied. This may eventually cause a localized
thinning of it. In the case of the patient who presented with
a late complication of lower abdominal pain and localized
opening in the peritoneum overlying part of the mesh
(mentioned under 3.1 complications) this thinning may be a
predisposing factor.
The complication of postoperative hematoma in the
cervical region (mentioned under 3.1 complications) may be
due to the supracervical hysterectomy. The later performed
salpingooophorectomy was conducted because of a necrosis
of the right ovary that may have been caused by a vascular
shortage after hysterectomy or by electrocoagulation during
hematoma revision.
Regarding the two patients who required a TVT, one had
persistent SUI which means that 5/6 patients who suffered
from SUI were cured after anatomical correction of the
prolapse alone. On the other hand there was only 1/10 patients
presenting with de-novo SUI. Due to the small sample size
it is not possible to compare the apparently good results to
other series, but as for this small sample results it seemed to be
better than in a lot of published series [9].
This may also be related to our therapeutic protocol,
since we only perform a colporrhaphy if the residual cysto-
or rectocele after apical stabilization corresponds to POP-Q
stage ≥ 2 (i.e., Aa, Ba, Ap, or Bp ≥ −1) to prevent undue
overcorrection. In this series 1/10 patients had received a
concomitant anterior and posterior colporrhaphy. Recently
Leclaire found that a greater reduction in point Aa is a risk
factor for de-novo SUI after sacropexy [9].
Figure 7: Same patient as in Figure 6, this time a T1-weighted
dataset, again with a coronal subvolume minimum intensity pro-
jection. Using the T1-weighted images, the contrast between the
implant and the surrounding tissue is even better. Due to the iron
oxide particles, a signal loss in the area of the implant is obvious
(arrows), which allows for exact identification of the implant.
In terms of reduction of urge symptoms, we had 7/10
patients in whom OAB-dry dissolved as well as 1/10 with
OAB-wet. Altogether 8/10 patients were relieved from OAB
symptoms after the operation which is a good result. These
results seem consistent with the results shown by abdominal
mesh placement displayed in a series [21].
Summarizing, we had a 100% apical healing rate in this
small sample of patients along with good anatomical results
in the anterior compartment. The functional outcome seems
to be favorable, yet a comparison with available data from
abdominal or laparoscopic sacropexy series is not possible
due to the small sample size.
In the ongoing debate on the use of meshes in prolapse
surgery the choice of the material plays a critical role. The
mesh we used is one with full ce-mark made up of PVDF.
Many data suggest that this material has favorable properties.
Comparison of PVDF and polypropylene (PP) in rodent
model showed a better biocompatibility and less foreign body
reaction with PVDF [22].
Furthermore it is well accepted that meshes for POP
surgery should bemacroporous.The used alloplasticmaterial
possesses a higher porosity under strain than most meshes
do [23]. Further data are required to evaluate to what extent
these properties may positively influence the postoperative
outcome in patients.
The application of meshes made of PVDF is widely used
in hernia repair. Berger andBientzle reported a large prospec-
tive study in 2009 [24]. As for the application in POP-surgery,
Noe´ et al. reported the use of this material in a prospective
clinical trial [25].
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The same mesh we applied was used for an abdominal
procedure of abdominal sacropexy described by Ja¨ger et al.
who reported a cure rate of urge incontinence of 77% [21].
Regarding our knowledge about mesh properties after
implantation it has to be stated that it is very limited in the
case of sacropexy. Since the standard meshes are “invisible”
for radiologic examinations or MRI the only way to evaluate
them after implantation is by means of ultrasound.
Performing pelvic floor ultrasound provides valuable
information about vaginalmeshes but rather few information
about meshes used for sacropexy because it is not capable
of showing the meshes lying above the pelvis. Thus the
relationship of the mesh to the sacral fixation point could not
be investigated well so far.
Further on, a possible complication—like mesh detach-
ment or compression of nerves or vessels in the presacral
space—occurring above the pelvis could not be investigated
through imaging so far and often required reoperation to
visualize the area of concern.
In a step toward higher patients’ safety effort was under-
taken to enhance the visibility of meshes in radiologic
examinations.
Kra¨mer et al. first introduced a concept forMRI visualiza-
tion of surgicalmeshes by integrating iron oxide particles into
them in 2010 [14].The first MRI visualization of an implanted
mesh for inguinal hernia repair was reported in 2013 [26].
In our serieswe had three patients inwhomweperformed
a MRI because of postoperative complaints. In these pre-
sented cases there was no need for surgical intervention since
a complication was ruled out through MRI.
So the use of MRI comprises the only nonoperative way
to visualize and evaluate the lay of an implanted mesh and
may reduce the need for reoperations in case of postoperative
complications. Additionally it gives the unique opportunity
for the evaluation of changing mesh characteristics over time
giving us new opportunities to study mesh behavior after
implantation. This may be helpful in better understanding of
causes for mesh related complications in POP surgery.
In this paper we presented the first in-human magnetic
resonance visualization of a prolapse mesh implant. The
performed MRIs showed a very good visualization of the
mesh in addition to the nearby structures and were helpful
in the management of postoperative complications.
5. Conclusion
Modified laparoscopic bilateral sacropexy (MLBS) is a feasi-
ble and safe operative procedure. The preliminary data are
encouraging, showing favorable anatomical and functional
outcome and good concomitant healing rates of SUI and
OAB. The MRI-visibility of the implanted mesh has a good
quality and is helpful in postoperative complication manage-
ment. For further evaluation we are planning to perform a
prospective study with a larger sample.
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